We are pushing the bounds of what is possible in developing treatments for serious diseases with unmet needs, but we cannot do this alone. Forging strategic partnerships with companies, universities and research institutions helps us realize the full potential of our science.

In order to share knowledge, resources and ideas that may best benefit patients, we are committed to alliances, partnerships and collaborations with major universities and other companies to bring additional discovery platforms and therapeutics forward. We also evaluate assets that have the potential to expand our pipeline, geographic reach or technological base. We enjoy working with like-minded partners who want to join forces to improve the lives of patients.

Additionally, we provide our investigational products and/or financial support for independent research by third parties in therapeutic areas of interest. We ensure that requests for Investigator-Initiated Research (IIRs) are submitted, reviewed and, if approved, conducted and funded in a standardized and consistent manner, in compliance with all applicable legal and ethical standards and obligations.

To contact our Business Development team, please e-mail bd@incyte.com.


Agenus - Logo of Agenus Inc.

Agenus Inc.

Antibody development collaboration

Biotheryx, Inc. logo

Biotheryx, Inc.

Discovery collaboration for oncology targeted protein degraders

Cellenkos logo


Global development collaboration

InnoCare logo

InnoCare Pharma Limited

Oncology commercialization collaboration in Asia

Logo of Innovent

Innovent Biologics (HK) Limited

Commercialization collaboration in Asia

Lilly - Logo of Eli Lilly and Company

Eli Lilly and Company

JAK inhibitor anti-inflammatory diseases and COVID-19 collaboration

MACROGENICS - Logo of Macrogenics, Inc.

MacroGenics, Inc.

Monoclonal antibody development collaboration

Maruho logo

Maruho Co., Ltd.

Topical JAK inhibitor development and commercialization collaboration in Japan

Merus - Logo of Merus N.V.

Merus N.V.

Bispecific antibody development collaboration

Morphosys logo

MorphoSys AG

Oncology commercialization collaboration

Novartis - Logo of Novartis International Pharmaceutical Ltd.

Novartis International Pharmaceutical Ltd.

Oncology collaboration

Syndax logo

Syndax Pharmaceuticals, Inc.

Monoclonal antibody development and commercialization collaboration